Connect with us

Hi, what are you looking for?

Prime Webinar GroupPrime Webinar Group

Politics

Pro-Israel Dem says those who won’t decry Hamas over Oct. 7 attack ‘have no business’ posing as humanitarians

Rep. Ritchie Torres, D-N.Y., an outspoken opponent of antisemitism, said Wednesday that those who refuse to speak out against the heinous acts Hamas perpetrated in Israel on Oct. 7, 2023 ‘have no business’ claiming to be humanitarians.

‘If you refuse to condemn Hamas for the murder, maiming, mutilation, rape, torture, and abduction of thousands of Jews and Israelis on October 7, then you have no business calling yourself a humanitarian,’ Torres wrote on X. 

‘A humanitarianism that devalues Jewish life is no humanitarianism at all, for it has been hollowed out by antisemitism,’ he added.

The congressman has been a strong voice of support for Israel.

‘The singular stumbling block to ending the war is the terrorist organization that barbarically began it: Hamas. Scapegoating Israel is so second nature to the international community that Hamas’ role in precipitating and perpetuating the war has been all but forgotten,’ Torres wrote on X earlier this month.

In another post on X this month he opined that ‘Antisemitism is the deadliest disease ever to afflict the human heart.’

In a post last month, he asserted, ‘If Israel is the sole country in the Middle East—indeed the world—for which you reserve the label ‘apartheid’—then your use of the term is probably propagandistic rather than principled and your purpose is not constructive criticism but the destructive delegitimation of Israel as a Jewish State.’

Rep. Torres says Biden Admin made

Torres has served in the U.S. House of Representatives since early 2021.

This post appeared first on FOX NEWS

You May Also Like

Editor's Pick

Some Sector Reshuffling But No New Entries/Exits Despite a backdrop of significant geopolitical events over the weekend, the market’s reaction appears muted — at...

Editor's Pick

Join Dave as he shares how he uses the power of Fibonacci retracements to anticipate potential turning points. He takes viewers through the process...

Editor's Pick

Jeffrey A. Singer In recent testimony before the Senate Appropriations Committee, Food and Drug Administration Commissioner Marty A. Makary, MD, said he favored streamlining...

Editor's Pick

Matt Mittelsteadt In recent weeks, the specifics of Congress’s proposed state AI regulatory moratorium have dominated AI policy discussions. Because it’s unclear if this...